Winston Laboratories, Inc., a wholly-owned subsidiary of Winston Pharmaceuticals, Inc…

Read The Full Article…Winston Laboratories, Inc. Receives Notice Of Compliance In Canada For CIVANEX™ (Civamide Cream) For Treatment Of Osteoarthritis Read more »

Molecular dermatology research and development innovator DermaGenoma, Inc. today announced that the PsoriasisDX Genetic Test for Psoriatic Arthritis (PsA) is now available as a CE Marked product under the European In Vitro Diagnostic Directive. CE Marking is required for certain product groups to indicate conformity with the essential requirements set out in European Directives…

Read [...] Read more »

Research on the population of black-legged ticks, which can transmit Lyme disease from host animals to humans, reinforces that it is important to take preventative measures when spending time outdoors…

Read The Full Article…Need For Protection Against Ticks That Carry Lyme Disease Read more »

Taking a few small steps toward protecting your knees when you are younger might help you avoid debilitating problems when you get older. Studies have shown that nearly half of adults will get knee arthritis in at least one knee by age 85. For obese people, the risk is even greater. “Every time [...] Read more »

The American Academy of Orthopaedic Surgeons (AAOS) has approved and released an evidence-based clinical practice guideline on “The Treatment of Glenohumeral Joint Osteoarthritis.” This major joint in the shoulder – the ball and socket joint – is sometimes affected by osteoarthritis, causing pain, loss of function, and reduced quality of life…

Read The Full Article…Shoulder Arthritis? [...] Read more »

DePuy Orthopaedics EMEA announces the introduction of Sigma® High Performance Partial Knee, the only partial knee replacement system designed to provide the complete solution to progressive osteoarthritis in active patients…

Read The Full Article…First Complete Surgical System Specifically Designed To Treat Progressive Osteoarthritis Of The Knee Is Launched In Europe Read more »

A new multi-disciplinary approach to osteoarthritis research in the UK was announced earlier this month with a 1.8 million pound programme comprising three clinical trials involving 300 people with osteoarthritis of the knee and a research team of radiologists, engineers, biomechanics, rheumatologists and physiotherapists…

Read The Full Article…New Multi-Disciplinary Approach To Osteoarthritis Research Announced [...] Read more »

A new multi-disciplinary approach to osteoarthritis research in the UK was announced earlier this month with a 1.8 million pound programme comprising three clinical trials involving 300 people with osteoarthritis of the knee and a research team of radiologists, engineers, biomechanics, rheumatologists and physiotherapists…

Read The Full Article…New Multi-Disciplinary Approach To Osteoarthritis Research Announced [...] Read more »

Allosteric modulation company Addex Pharmaceuticals Ltd. (SWISS: ADXN) announced that its preclinical drug candidate ADX71943 was effective in a model of osteoarthritis pain. ADX71943 is a potent and selective positive allosteric modulator of gamma-aminobutyric acid subtype B (GABA-B) receptors…

Read The Full Article…Addex Drug Candidate Effective In Osteoarthritis Pain Model Read more »

A pioneering trial to treat knee arthritis by using patients’ own stem cells to regrow worn out cartilage is to start in the UK later this year; if successful the new technique offers hope to millions of people who suffer with the pain and stiffness of osteoarthritis, although the researchers warn that the [...] Read more »